Research Updates
Insights from ESC Cardio-Oncology Conference
Read more: Insights from ESC Cardio-Oncology ConferenceI recently attended ESC Cardio-Oncology 2026 in Vienna. Alongside other major international gatherings like Global Cardio-Oncology Summit, the ESC Cardio-Oncology Conference remains a vital forum for experts at the intersection of cardiology and cancer care. This trip wasn’t just…
Predict Better. Protect Better. Now Let’s Build Cardio-Oncology Service Better, Together.
Read more: Predict Better. Protect Better. Now Let’s Build Cardio-Oncology Service Better, Together.A new state-of-the-art review on risk prediction in cardio-oncology, and an invitation to help build the tools this field still needs.
When “Moderate” Isn’t Moderate: A New Way to Assess Risk in Aortic Stenosis
Read more: When “Moderate” Isn’t Moderate: A New Way to Assess Risk in Aortic StenosisThe moderate aortic stenosis risk score is a new clinical tool designed to predict who is truly at risk of cardiac death or heart failure hospitalisation — and who is likely to do well. If you have…
Troponin Up on Immune Checkpoint Inhibitor: Panic, Pause, or Press On?
Read more: Troponin Up on Immune Checkpoint Inhibitor: Panic, Pause, or Press On?For clinicians on the front line, including GPs, emergency physicians, and oncologists, the question is what to do when a troponin comes back elevated in someone receiving immunotherapy. Not every troponin rise means myocarditis. But missing the…
